Pathological Correlates of Late Drug-Eluting Stent Thrombosis
Top Cited Papers
- 8 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 115 (18) , 2435-2441
- https://doi.org/10.1161/circulationaha.107.693739
Abstract
Background— Late stent thrombosis (LST) after Cypher and Taxus drug-eluting stent placement has emerged as a major concern. Although the clinical predictors of LST have been reported, specific morphological and histological correlates of LST remain unknown. Methods and Results— From a registry totaling 81 human autopsies of drug-eluting stents, 46 (62 lesions) had a drug-eluting stent implanted >30 days. We identified 28 lesions with thrombus and compared those with 34 of similar duration without thrombosis using computer-guided morphometric and histological analyses. LST was defined as an acute thrombus within a coronary artery stent in place >30 days. Multiple logistic generalized estimating equations modeling demonstrated that endothelialization was the best predictor of thrombosis. The morphometric parameter that best correlated with endothelialization was the ratio of uncovered to total stent struts per section. A univariable logistic generalized estimating equations model of occurrence of thrombus in a stent section versus ratio of uncovered to total stent struts per section demonstrated a marked increase in risk for LST as the number of uncovered struts increased. The odds ratio for thrombus in a stent with a ratio of uncovered to total stent struts per section >30% is 9.0 (95% CI, 3.5 to 22). Conclusions— The most powerful histological predictor of stent thrombosis was endothelial coverage. The best morphometric predictor of LST was the ratio of uncovered to total stent struts. Heterogeneity of healing is a common finding in drug-eluting stents with evidence of LST and demonstrates the importance of incomplete healing of the stented segment in the pathophysiology of LST.Keywords
This publication has 19 references indexed in Scilit:
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJournal of the American College of Cardiology, 2006
- Pathology of Drug-Eluting Stents in HumansJournal of the American College of Cardiology, 2006
- Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent PlacementCirculation, 2006
- Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting StentsCirculation, 2005
- Relationship between angiographic late loss and target lesion revascularization after coronary stent implantationJournal of the American College of Cardiology, 2005
- Vascular Healing 4 Years After the Implantation of Sirolimus-Eluting Stent in HumansCirculation, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Sirolimus-Eluting Stent Implanted in Human Coronary Artery for 16 MonthsCirculation, 2003
- Review of Software to Fit Generalized Estimating Equation Regression ModelsThe American Statistician, 1999